ADENOCARCINOMA OF LUNG
Clinical trials for ADENOCARCINOMA OF LUNG explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF LUNG trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug combo enters key testing phase
Disease control OngoingThis study is testing a new drug, PF-07220060, to see if it is safe and can help control advanced cancers. It will be given alone and in combination with other standard hormone therapies. The trial is for people with certain advanced solid tumors, including breast, prostate, and …
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
CRISPR-Engineered immune cells target advanced lung cancer
Disease control TerminatedThis trial aimed to test a new cell therapy for metastatic non-small cell lung cancer. It planned to use a patient's own tumor-fighting immune cells, genetically edited with CRISPR technology to remove a molecular 'brake' called CISH. The goal was to see if these supercharged cel…
Matched conditions: ADENOCARCINOMA OF LUNG
Phase: PHASE1, PHASE2 • Sponsor: Intima Bioscience, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC